Emily was the first child enrolled in the phase I clinical trial (known
as CART-19 or CTL019) in April 2012. Her T-cells (a type of white blood
cell) were collected from her body, and then, in a process using a
disabled form of the human immunodeficiency virus (HIV), the T-cells
were genetically reprogrammed to recognize and attack cancer cells. When
the modified T-cells were put back into Emily she became very sick and
spent several weeks in the intensive care unit on a ventilator. At one
point her doctor said she had only a 1 in 1000 chance of surviving the
night. Not only did Emily survive that night, but a few weeks later her
family was given the miracle they had prayed for: the T-cell therapy
worked. Doctors couldn’t detect a single cancer cell in her body. Today, Emily is nearing three years cancer free.
Read more of Emily's story here and learn how you can contribute to this revolution Tell me more !
Saturday, February 28, 2015
Subscribe to:
Posts (Atom)
